Column GROUP Iii-a, L.P., 10% Owner at Revolution Medicines, Inc. (RVMD), sold 4,054,312 shares at $36.40 ($147.6M) on 2020-11-16, disclosed to the SEC on 2020-11-18.
Open-market sale of $147.6M RVMD by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $36.40 | 952,023 | $34.7M | 23.5% |
| 2 | $36.40 | 952,023 | $34.7M | 23.5% |
| 3 | $36.40 | 1,075,133 | $39.1M | 26.5% |
| 4 | $36.40 | 1,075,133 | $39.1M | 26.5% |
| Total | $36.40 avg | 4,054,312 | $147.6M | 100% |
| Filing → |
| SRZN | BUY | 2024-04-17 | $6.0M | — | Filing → |
| TNYA | BUY | 2024-02-14 | $10.0M | — | Filing → |
| TNYA | BUY | 2023-02-10 | $3.9M | — | Filing → |